FRANKFURT, April 1 (Reuters) - Roche, the world's largest cancer drugmaker, is ready to collaborate with rivals to find new combination therapies for multi-pronged treatments, its chief executive said.
Severin Schwan said the company was investing very heavily in a new wave of cancer immunotherapy drugs, where finding combination therapies to attack tumours on different fronts would be "extremely important".
14:49 Trump warns of ‘retribution’ for companies that offshore jobs, threatening 35 percent tariff13
18:05 DP World, Quebec's Caisse to create C$5 billion investment vehicle14
13:37 GoPro to cut about 15 percent of workforce13
23:59 Samsung Electronics says reviewing shift to holding company structure15